1. Ribeiro LF, Lopes EM, Kishi LT, Ribeiro LFC, Menegueti MG, Gaspar GG, et al. Microbial community profiling in intensive care units expose limitations in current sanitary standards. Front Public Health. 2019;7(AUG):1–14
2. Gómez-De Rueda F, Martinez-Nogueras R, Tena-Sempere ME, Elosegui-Horno I, Robles-Rodríguez L, Horno-Ureña F. Epidemiological aspects and prevalence study of nosocomial infections in a general hospital of specialties: Retrospective analysis 2012–2017. Eur J Hosp Pharm. 2019;26(6):339–42
3. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–27
4. World Health Organization. Antimicrobial resistance: Prioritization of Pathogens to guide Research and Development of New antibiotics [Internet]; 2017. [cited 2020 Feb 8]. Retrieved from: https://www.who.int/medicines/areas/rational_use/prioritization-ofpathogens/en/
5. Patil A, Banerji R, Kanojiya P, Koratkar S, Saroj S. Bacteriophages for ESKAPE: Role in pathogenicity and measures of control. Expert Rev Anti-Infect Ther. 2021;19(7):845–65. https://doi.org/10.1080/14787210.2021.1858800
6. Mahfouz N, Ferreira I, Beisken S, von Haeseler A, Posch AE. Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: A systematic review. J Antimicrob Chemother. 2020;75(11):3099–108
7. O’Neil J. Review on antibiotic resisitance. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Heal Wealth Nations. 2014 (December):1–16. Retrieved from: https://amr-review.org/sites/default/files/AMR Review Paper -. Tackling a crisis for the health and wealth of nations_1.pdf
8. Finley RL, Collignon P, Larsson DGJ, Mcewen SA, Li XZ, Gaze WH, et al. The scourge of antibiotic resistance: The important role of the environment. Clin Infect Dis. 2013;57(5):704–10
9. Jensen CS, Nielsen SB, Fynbo L. Risking antimicrobial Resistance: A One Health Study of antibiotic Use and Its Societal Aspects BT - Risking antimicrobial Resistance: A collection of one-health studies of antibiotics and its social and health consequences. In: Jensen CS, Nielsen SB, Fynbo L, editors. Cham: Springer International Publishing; 2019. p. 1–24. https://doi.org/10.1007/978-3-319-90656-0_1
10. Tripathi V, Tripathi P. Antibiotic resistance genes: An emerging environmental polluant. Environ Sci Eng (Subser Environ Sci). 2017;(9783319462479):iii–iv:183–201
11. Agaba P, Tumukunde J, Tindimwebwa JVB, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: A cross sectional study. BMC Res Notes. 2017;10(1):349
12. Fernando SA, Gray TJ, Gottlieb T. Healthcare-acquired infections: Prevention strategies. Intern Med J. 2017;47(12):1341–51
13. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006;166(18):1945–51
14. Rello J, Kalwaje Eshwara V, Lagunes L, Alves J, Wunderink RG, Conway-Morris A, et al. A global priority list of the TOp TEn resistant microorganisms (TOTEM) study at intensive care: A prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis. 2019;38(2):319–23
15. Arias CA, Murray BE. The rise of the Enterococcus: Beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–78
16. Blanc DS. The use of molecular typing for epidemiological surveillance and investigation of endemic nosocomial infections. Infect Genet Evol. 2004;4(3):193–7
17. Han JH, Sullivan N, Leas BF, Pegues DA, Kaczmarek JL, Umscheid CA. Cleaning Hospital room surface to prevent health care-associated infections. Ann Intern Med. 2015;163(8):598–607
18. BrCAST. Orientações do EUCAST para a detecção de mecanismos de resistência e resistências específicas de importância clínica e/ou epidemiológica. Retrieved from: http://brcast.org.br/documentos/;46; 2018
19. Brasil. Portaria N° 64, de 11 de dezembro de 2018 [Internet]; 2018. Retrieved from: https://www.inca.gov.br/tipos-de-cancer/cancer-anal. p. 1
20. Snoad C, Nagel C, Bhattacharya A, Thomas E. The Effectiveness of Sanitary Inspections as a Risk Assessment Tool for Thermotolerant Coliform Bacteria Contamination of Rural Drinking Water: A Review of Data from West Bengal, India. Am J Trop Med Hyg. 2017 Apr;96(4):976-983. doi: 10.4269/ajtmh.16-0322. Epub 2017 Jan 23. PMID: 28115676; PMCID: PMC5392651.
21. Chemaly RF, Simmons S, Dale C, Ghantoji SS, Rodriguez M, Gubb J et al. The role of the healthcare environment in the spread of multidrug-resistant organisms: Update on current best practices for containment. Ther Adv Infect Dis. 2014;2(3–4):79–90
22. Chaoui L, Mhand R, Mellouki F, Rhallabi N. Contamination of the surfaces of a health care environment by multidrug-resistant (MDR) bacteria. Int J Microbiol. 2019;2019:3236526
23. Gray JW, Mahida N. How do you solve a problem like multidrug-resistant Gram-negative bacteria? J Hosp Infect. 2016;92(1):1–2. http://dx.doi.org/10.1016/j.jhin.2015.11.005
24. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:1–8
25. Molter G, Seifert H, Mandraka F, Kasper G, Weidmann B, Hornei B, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: A multi-level strategic management approach. J Hosp Infect. 2016;92(2):194–8. http://dx.doi.org/10.1016/j.jhin.2015.11.007
26. Köhler AT, Rodloff AC, Labahn M, Reinhardt M, Truyen U, Speck S. Evaluation of disinfectant efficacy against multidrug-resistant bacteria: A comprehensive analysis of different methods. Am J Infect Control. 2019;47(10):1181–7
27. Ikeda T, Ledwith A, Bamford CH, Hann RA. Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta. 1984 Jan 11;769(1):57-66. doi: 10.1016/0005-2736(84)90009-9. PMID: 6691980.
29. Tondo EC, Machado TRM, Malheiros Pda S, Padrão DK, de Carvalho AL, Brandelli A. Adhesion and biocides inactivation of Salmonella on stainless steel and polyethylene. Braz J Microbiol. 2010;41(4):1027–37
30. Wessels S, Ingmer H. Modes of action of three disinfectant active substances: A review. Regul Toxicol Pharmacol. 2013;67(3):456–67. http://dx.doi.org/10.1016/j.yrtph.2013.09.006
31. Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Front Microbiol. 2019;10(APR):539
32. De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):1–49
33. Santajit S, Indrawattana N. Mechanisms of antimicrobial resistance in Pasteurellaceae. Pbiomed Res Int. 2016;2016(1155):1–8
34. Weber KL, Lesassier DS, Kappell AD, Schulte KQ, Westfall N, Albright NC, et al. Simulating transmission of ESKAPE pathogens plus C. difficile in relevant clinical scenarios. BMC Infect Dis. 2020;20(1):1–15
35. Ma YX, Wang CY, Li YY, Li J, Wan QQ, Chen JH, et al. Considerations and caveats in combating ESKAPE pathogens against nosocomial infections. Adv Sci (Weinh). 2020;7(1):1901872
36. Abbas A, Srivastava P, Nirwan PS. Prevalence of MLSB resistance and observation of erm A & erm C Genes at a tertiary care hospital. J Clin Diagn Res. 2015;9(6):DC08–DC10
37. Yahav D, Giske CG, Grāmatniece A, Abodakpi H, Tam VH, Leibovici L. New β-lactam–β-lactamase inhibitor combinations. Clin Microbiol Rev. 2020;34(1):1–61
38. Tsitou VM, Mitov I, Gergova R. Relationship between MLSB resistance and the prevalent virulence genotypes among Bulgarian Staphylococcus aureus isolates. Acta Microbiol Immunol Hung. 2020;68(1):55–61
39. Cerceo E, Deitelzweig SB, Sherman BM, Amin AN. Multidrug-resistant Gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412–31
40. Walger P. Rationaler Einsatz von Antibiotika. Internist. 2016;57(6):551–68
41. Wille I, Mayr A, Kreidl P, Brühwasser C, Hinterberger G, Fritz A, et al. Cross-sectional point prevalence survey to study the environmental contamination of nosocomial pathogens in intensive care units under real-life conditions. J Hosp Infect. 2018;98(1):90–5. https://doi.org/10.1016/j.jhin.2017.09.019
42. Vermeil T, Peters A, Kilpatrick C, Pires D, Allegranzi B, Pittet D. Hand hygiene in hospitals: Anatomy of a revolution. J Hosp Infect. 2019;101(4):383–92. https://doi.org/10.1016/j.jhin.2018.09.003
43. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control. 2006;34(5)(suppl. 1):S3–10; discussion S64
44. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2008;46(5):678–85
45. Hardy KJ, Gossain S, Henderson N, Drugan C, Oppenheim BA, Gao F, et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect. 2007;66(4):360–8
46. Ortega Morente E, Fernández-Fuentes MA, Grande Burgos MJ, Abriouel H, Pérez Pulido R, Gálvez A. Biocide tolerance in bacteria. Int J Food Microbiol. 2013;162(1):13–25. http://dx.doi.org/10.1016/j.ijfoodmicro.2012.12.028
47. Gerba CP. Quaternary ammonium biocides: Efficacy in application. Appl Environ Microbiol. 2015;81(2):464–9.